HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

2Xideas AG's Holding History (CIK: 0001843587)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 104,801 Value ($000) $7,053 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 158,824 Value ($000) $11,648 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 184,546 Value ($000) $9,600 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 246,802 Value ($000) $15,748 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 379,240 Value ($000) $18,131 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 305,587 Value ($000) $17,492 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 498,957 Value ($000) $26,125 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 515,462 Value ($000) $20,969 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 544,166 Value ($000) $20,112 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 600,799 Value ($000) $22,951 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 645,288 Value ($000) $23,276 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 547,619 Value ($000) $20,914 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 416,586 Value ($000) $23,704 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 226,471 Value ($000) $8,955 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 324,619 Value ($000) $14,283 Avg Close $43.25 Range $36.95 - $48.58